期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
CYP2C19 polymorphism influences Helicobacter pylori eradication 被引量:36
1
作者 Chao-Hung kuo Chien-Yu Lu +7 位作者 Hsiang-Yao Shih Chung-Jung Liu Meng-Chieh Wu Huang-Ming Hu Wen-Hung Hsu Fang-Jung Yu Deng-Chyang Wu fu-chen kuo 《World Journal of Gastroenterology》 SCIE CAS 2014年第43期16029-16036,共8页
The known factors that have contributed to the decline of Helicobacter pylori (H. pylori) eradication rate include antibiotic resistance, poor compliance, high gastric acidity, high bacterial load, and cytochrome P450... The known factors that have contributed to the decline of Helicobacter pylori (H. pylori) eradication rate include antibiotic resistance, poor compliance, high gastric acidity, high bacterial load, and cytochrome P450 2C19 (CYP2C19) polymorphism. Proton pump inhibitor (PPI) is important in the eradication regimen. The principal enzyme implicated in the metabolism of PPIs is CYP2C19. The effects of PPI depend on metabolic enzyme, cytochrome P450 enzymes, and CYP2C19 with genetic differences in the activity of this enzyme (the homozygous EM, heterozygous EM (HetEM), and poor metabolizer). The frequency of the CYP2C19 polymorphism is highly varied among different ethnic populations. The CYP2C19 genotype is a cardinal factor of H. pylori eradication in patients taking omeprazole- based or lansoprazole-based triple therapies. In contrast, the CYP2C19 polymorphism has no significant effect on the rabeprazole-based or esomeprazole-based triple therapies. The efficacy of levofloxacin-based rescue triple therapy might be also affected by the CYP2C19 polymorphism, but CYP2C19 genotypes did not show obvious impact on other levofloxacin-based rescue therapies. Choice of different PPIs and/or increasing doses of PPIs should be individualized based on the pharmacogenetics background of each patient and pharmacological profile of each drug. Other possible factors influencing gastric acid secretion (e.g., IL-1&#x003b2;- 511 polymorphism) would be also under consideration. 展开更多
关键词 Helicobacter pylori CYP2C19 POLYMORPHISM Eradication RABEPRAZOLE Omeprazole LANSOPRAZOLE PANTOPRAZOLE ESOMEPRAZOLE
下载PDF
Diagnosis of Helicobacter pylori infection: Current options and developments 被引量:70
2
作者 Yao-Kuang Wang fu-chen kuo +7 位作者 Chung-Jung Liu Meng-Chieh Wu Hsiang-Yao Shih Sophie SW Wang Jeng-Yih Wu Chao-Hung kuo Yao-Kang Huang Deng-Chyang Wu 《World Journal of Gastroenterology》 SCIE CAS 2015年第40期11221-11235,共15页
Accurate diagnosis of Helicobacter pylori(H. pylori) infection is a crucial part in the effective management of many gastroduodenal diseases. Several invasive and non-invasive diagnostic tests are available for the de... Accurate diagnosis of Helicobacter pylori(H. pylori) infection is a crucial part in the effective management of many gastroduodenal diseases. Several invasive and non-invasive diagnostic tests are available for the detection of H. pylori and each test has its usefulness and limitations in different clinical situations. Although none can be considered as a single gold standard in clinical practice,several techniques have been developed to give the more reliable results. Invasive tests are performed via endoscopic biopsy specimens and these tests include histology,culture,rapid urease test as well as molecular methods. Developments of endoscopic equipment also contribute to the real-time diagnosis of H. pylori during endoscopy. Urea breathingtest and stool antigen test are most widely used noninvasive tests,whereas serology is useful in screening and epidemiological studies. Molecular methods have been used in variable specimens other than gastric mucosa. More than detection of H. pylori infection,several tests are introduced into the evaluation of virulence factors and antibiotic sensitivity of H. pylori,as well as screening precancerous lesions and gastric cancer. The aim of this article is to review the current options and novel developments of diagnostic tests and their applications in different clinical conditions or for specific purposes. 展开更多
关键词 HELICOBACTER PYLORI DIAGNOSIS INVASIVE NONINVASIVE
下载PDF
Capsaicin-induced cell death in a human gastric adenocarcinoma cell line 被引量:7
3
作者 Yi-Ching Lo Yuan-Chieh Yang +6 位作者 I-Chen Wu fu-chen kuo Chi-Ming Liu Hao-Wei Wang Chao-Hung kuo Jeng-Yi Wu Deng-Chyang Wu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第40期6254-6257,共4页
AIM Capsaicin, a pungent ingredient found in red pepper, has long been used in spices, food additives, and drugs. Cell death induced by the binding of capsaidn was examined in a human gastric adenocarcinoma cell line ... AIM Capsaicin, a pungent ingredient found in red pepper, has long been used in spices, food additives, and drugs. Cell death induced by the binding of capsaidn was examined in a human gastric adenocarcinoma cell line (AGS cells). METHODS: By using XTT-based cytotoxicity assay, flow cytometry using the TUNEL method, and quantitation of DNA fragmentation, both cell death and DNA fragmentaUon were detected in AGS cells treated with capsaicin. By using Western blotting methods, capsaicin reduced the expression of Bcl-2, the antiapoptotic protein, in AGS cells in a concentration-dependent manner. RESULTS- After incubation of AGS cells with capsaicin for 24 h, cell viability decreased significantly in a dose-dependent manner. After incubation of AGS cells with capsaicin for 24 h, apoptotic bodies also significantly increased, and were again correlated with the dose of capsaicin. When the concentration of capsaicin was 1 mmol/L, the amount of DNA fragments also increased. Similar results were also in the lower traces. CONCLUSION: These results suggest that capsaicin- induced cell death might be via a Bcl-2 sensitive apoptotic pathway. Therefore, capsaicin might induce protection from gastric cancer. 展开更多
关键词 CAPSAICIN Human gastric adenocarcinoma Apoptosis Bcl-2
下载PDF
Evaluation of urine ELISA test for detecting Helicobacter pylori infection in Taiwan: A prospective study 被引量:2
4
作者 fu-chen kuo Sheng-Wen Wang +5 位作者 I-Chen Wu Fang-Jung Yu Yuan-Chieh Yang Jeng-Yih Wu Wen-Ming Wang Deng-Chyang Wu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第35期5545-5548,共4页
AIM: To evaluate the diagnostic accuracy and clinical utility of a new ELISA (URINELISA) test for detecting Helicobacter pylori (H pylorl) antibody in the urine of Taiwan Residents population. METHODS: In this p... AIM: To evaluate the diagnostic accuracy and clinical utility of a new ELISA (URINELISA) test for detecting Helicobacter pylori (H pylorl) antibody in the urine of Taiwan Residents population. METHODS: In this prospective study, 317 consecutive dyspeptic patients (171 men, 146 women; mean age, 51.0 years) were included. They underwent gastroendoscopy for evaluation. Invasive tests, including culture, histology, and rapid urease test (RUT), and non-invasive ^13C-urea breath test were preformed. At the same time, urine specimens were collected for URINELISA. The status of H pylori infection was considered as positive when either culture was positive, or when two of the other, RUT, histology or 13C-UBT, were positive. RESULTS: The sensitivity, specificity, positive predictive value, and negative predictive value of URINELISA are 91.7% (211/230), 90.8% (79/87), 96.3% (211/219), and 80.6% (79/98) respectively. CONCLUSION: This URINELISA test is reliable, inexpensive and easy-to-use. The high diagnostic accuracy warrants the use of URINELISA as a first-line screening tool for diagnosis of Hpyloriinfection in untreated patients. 展开更多
关键词 H pylori URINELISA
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部